These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1249208)

  • 1. Studies on the structural abnormality of fibrinogen Paris I.
    Mosesson MW; Amrani DL; Ménaché D
    J Clin Invest; 1976 Mar; 57(3):782-90. PubMed ID: 1249208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma').
    Wolfenstein-Todel C; Mosesson MW
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5069-73. PubMed ID: 6933547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A re-examination of the cleavage of fibrinogen and fibrin by plasmin.
    Ferguson EW; Fretto LJ; McKee PA
    J Biol Chem; 1975 Sep; 250(18):7210-8. PubMed ID: 126232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact with the N termini in the central E domain enhances the reactivities of the distal D domains of fibrin to factor XIIIa.
    Samokhin GP; Lorand L
    J Biol Chem; 1995 Sep; 270(37):21827-32. PubMed ID: 7665605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome".
    Mosesson MW; Siebenlist KR; Hainfeld Jf; Wall JS; Soria J; Soria C; Caen JP
    J Clin Invest; 1996 May; 97(10):2342-50. PubMed ID: 8636415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin.
    Marder VJ; Budzynski AZ; Barlow GH
    Biochim Biophys Acta; 1976 Mar; 427(1):1-14. PubMed ID: 130927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative abnormality of an Aalpha chain molecular weight form in the fibrinogen of cirrhotic patients.
    Weinstein MJ; Deykin D
    Br J Haematol; 1978 Dec; 40(4):617-30. PubMed ID: 728374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmic degradation of human fibrinogen. IV. Identification of subunit chain remnants in fragment Y.
    Furlan M; Seelich T; Beck EA
    Biochim Biophys Acta; 1975 Jul; 400(1):112-20. PubMed ID: 125108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Position of gamma-chain carboxy-terminal regions in fibrinogen/fibrin cross-linking mixtures.
    Siebenlist KR; Meh DA; Mosesson MW
    Biochemistry; 2000 Nov; 39(46):14171-5. PubMed ID: 11087365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa).
    Kanaide H; Shainoff JR
    J Lab Clin Med; 1975 Apr; 85(4):574-97. PubMed ID: 1168234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-Chain cross-linking in fibrin(ogen) Marburg.
    Sobel JH; Trakht I; Wu HQ; Rudchenko S; Egbring R
    Blood; 1995 Aug; 86(3):989-1000. PubMed ID: 7620190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains.
    Siebenlist KR; Meh DA; Mosesson MW
    Biochemistry; 1996 Aug; 35(32):10448-53. PubMed ID: 8756701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking.
    Shainoff JR; Urbanic DA; DiBello PM
    J Biol Chem; 1991 Apr; 266(10):6429-37. PubMed ID: 1672529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen.
    Francis CW; Marder VJ; Martin SE
    J Biol Chem; 1980 Jun; 255(12):5599-604. PubMed ID: 6445903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmic degradation of human fibrinogen. III. Molecular model of the plasmin-resistant disulfide knot in monomeric fragment D.
    Furlan M; Kemp G; Beck EA
    Biochim Biophys Acta; 1975 Jul; 400(1):95-111. PubMed ID: 125109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and chromatographic heterogeneity of normal plasma fibrinogen associated with the presence of three gamma-chain types with distinct molecular weights.
    Francis CW; Kraus DH; Marder VJ
    Biochim Biophys Acta; 1983 Apr; 744(2):155-64. PubMed ID: 6404305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfibrinogenemia associated with liver disease.
    Palascak JE; Martinez J
    J Clin Invest; 1977 Jul; 60(1):89-95. PubMed ID: 874092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of variant gamma chains and sialic acid content of fibrinogen upon its interactions with ADP-stimulated human and rabbit platelets.
    Harfenist EJ; Packham MA; Mustard JF
    Blood; 1984 Dec; 64(6):1163-8. PubMed ID: 6437459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.